Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy

Korean journal of pediatrics
Byung Gyu YoonHoon Kook

Abstract

It is uncommon for pediatric patients with rhabdomyosarcoma to present with clinical and/or laboratory features of disseminated intravascular coagulation (DIC). We report a case of metastatic alveolar rhabdomyosarcoma with severe bleeding because of DIC in a 13-year-old boy. He experienced persistent oozing at the site of a previous operation, gross hematuria, and massive epistaxis. Two weeks after initiating combination chemotherapy consisting of vincristine, doxorubicin, and cyclophosphamide, the patients' laboratory indications of DIC began to resolve. During this period, the patient received massive blood transfusion of a total of 311 units (26 units of red blood cells, 26 units of fresh frozen plasma, 74 units of platelet concentrates, 17 units of single donor platelets, and 168 units of cryoprecipitate), antithrombin-III and a synthetic protease inhibitor. Despite chemotherapy and radiation therapy, he died 1 year later because of disease progression. In children with metastatic rhabdomyosarcoma and massive DIC, prompt chemotherapy and aggressive supportive care is important to decrease malignancy-triggered procoagulant activities.

References

Dec 22, 1999·Circulation·T PernerstorferB Jilma
Dec 12, 2001·Seminars in Thrombosis and Hemostasis·T Barbui, A Falanga
Jun 9, 2004·Critical Reviews in Oncology/hematology·Marcello De Cicco
Aug 2, 2006·Critical Care : the Official Journal of the Critical Care Forum·Marcel Levi, Steven M Opal
Mar 17, 2009·Best Practice & Research. Clinical Haematology·Marcel Levi
Nov 10, 2012·Case Reports in Oncology·Ru-Wen Teh, Daphne T Tsoi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.